1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Pharmacin

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Shenzhen Guangdong China

Primary Industry

Pharmaceuticals

About

Established in 2016 and based in Shenzhen, China, Pharmacin is a pharmaceutical company that focuses on the R&D, and production of modified new drugs. It has additional offices in the US. Ms. Xu, the company's CEO, has 15 experience in drug discovery and development in international pharmaceutical companies, including Novartis and Boehringer Ingelheim, who focuses on new drug targets for immunology and cardiovascular disease. It develops modified new drugs for oncology, endocrine, psychiatric, and immunology diseases. The pipe products,HLK-1001 for oncology, and HLK-6002 and HLK-6006 for immunology diseases, have entered into the clinial phase. The company adopts many technologies, such as insoluble drug solubilization technology, slow and controlled release technology, freeze-drying technology, and external preparation technology.
Current Investors
Kaitai Capital, China Reform Tus Fund, Ruihong Investment

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Mental Health Services, Pharmaceutical Research & Development
Website
www.pharmacin.com
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.